Neoadjuvant chemotherapy is an effective way of managing elderly women with advanced-stage ovarian cancer

被引：0
|
作者：
Glasgow, M. [1 ]
Yu, H. [1 ]
Rutherford, T. [1 ]
Azodi, M. [1 ]
Silasi, D. [1 ]
Santin, A. [1 ]
Schwartz, P. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
331
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [21] Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer
    Hinchcliff, E. M.
    Melamed, A.
    Bregar, A. J.
    Diver, E. J.
    Clemmer, J. T.
    del Carmen, M. G.
    Rauh-Hain, J. A.
    Schorge, J. O.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 69 - 70
  • [22] Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer
    Hinchcliff, Emily
    Melamed, Alexander
    Bregar, Amy
    Diver, Elisabeth
    Clemmer, Joel
    Del Carmen, Marcela
    Schorge, John O.
    Rauh-Hain, J. Alejandro
    GYNECOLOGIC ONCOLOGY, 2018, 148 (01) : 168 - 173
  • [23] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [24] Clinical experience in chemotherapy treatment for advanced-stage ovarian cancer
    Dumitru, M.
    Fagarasanu, Monica
    Cezar, Cristina
    Badescu, S.
    Tudosa, Rodica
    Soloviev, D.
    Vartej, P.
    GINECO RO, 2009, 5 (04): : 252 - 256
  • [25] Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
    Aletti, Giovanni D.
    Long, Harry J.
    Podratz, Karl C.
    Cliby, William A.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (01) : 212 - 216
  • [26] Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?
    Al Mutairi, Nashmia
    Le, Tien
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2019, 41 (02) : 185 - 190
  • [27] Cancer center case volume is associated with differences in the effectiveness of neoadjuvant chemotherapy for advanced-stage epithelial ovarian cancer
    Abel, Mary Kathryn
    Mazina, Varvara
    Bregar, Amy
    Gockley, Allison
    del Carmen, Marcela
    Eisenhauer, Eric
    Nitecki, Roni
    Rauh-Hain, Jose
    Dottino, Joseph
    Melamed, Alexander
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S84 - S85
  • [28] Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease
    Ferron, Jean-Guillaume
    Uzan, Catherine
    Rey, Annie
    Gouy, Sebastien
    Pautier, Patricia
    Lhomme, Catherine
    Duvillard, Pierre
    Morice, Philippe
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 147 (01) : 101 - 105
  • [29] Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer
    Thomas Ng
    Ariel E. Birnbaum
    Jacques P. Fontaine
    David Berz
    Howard P. Safran
    Thomas A. Dipetrillo
    Annals of Surgical Oncology, 2010, 17 : 476 - 482
  • [30] Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer
    Ng, Thomas
    Birnbaum, Ariel E.
    Fontaine, Jacques P.
    Berz, David
    Safran, Howard P.
    Dipetrillo, Thomas A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 476 - 482
12345